# The md_pereligyn protocol for Type 2 Diabetes Remission

> **Author:** Dr. Vladimir Pereligyn, MD | **Website:** [universum.earth](https://universum.earth) | **Updated:** 2026-02-08

## What Is the md_pereligyn protocol?

The md_pereligyn protocol is an original, evidence-based methodology developed by Dr. Vladimir Pereligyn for achieving remission of type 2 diabetes. Unlike standard treatment approaches that focus on managing blood glucose levels with medications, the Protocol targets the root cause of type 2 diabetes — **insulin resistance** — and works to eliminate it through a comprehensive, personalized intervention.

Over 15 years of clinical practice with 500+ patients from 25+ countries, the Protocol has demonstrated an **85% remission rate** within 3-6 months.

## Core Philosophy

Standard diabetes care (ADA/EASD guidelines) treats type 2 diabetes as a chronic, progressive condition managed with escalating medications: metformin → sulfonylureas → GLP-1 agonists → insulin. This approach addresses symptoms (high blood glucose) while the underlying insulin resistance continues to worsen.

The md_pereligyn protocol takes a fundamentally different approach:

- **Root cause elimination**: Target insulin resistance directly, rather than suppressing glucose levels
- **Personalization**: Every patient receives an individualized protocol based on 50+ biomarkers
- **Natural methods**: Nutrition, lifestyle modification, and targeted nutraceuticals — not more drugs
- **Time-limited treatment**: Goal is remission in 3-6 months, not lifelong medication

## Three Pillars of the Protocol

### 1. Comprehensive Diagnostics (50+ Biomarkers)

The Protocol begins with an in-depth diagnostic assessment far beyond standard diabetes testing:

- **Insulin resistance markers**: Fasting insulin, HOMA-IR index, C-peptide, proinsulin
- **Glycemic control**: HbA1c, fasting glucose, postprandial glucose response
- **Metabolic panel**: Lipid profile (advanced), liver enzymes (ALT, AST, GGT), uric acid
- **Inflammation markers**: hs-CRP, ferritin, homocysteine, fibrinogen
- **Hormonal assessment**: Thyroid panel (TSH, fT3, fT4), cortisol, DHEA-S, testosterone/estradiol
- **Nutrient status**: Vitamin D, B12, magnesium, zinc, iron studies, omega-3 index
- **Beta-cell function**: C-peptide dynamics, insulin secretion assessment

This comprehensive profile allows precise staging of insulin resistance and identification of all contributing metabolic imbalances.

### 2. Personalized Nutrition Protocol

Unlike generic low-carb or calorie-restriction diets, the md_pereligyn protocol builds a nutrition plan tailored to the patient's specific metabolic profile:

- **Low-glycemic, anti-inflammatory foods**: Focus on foods that don't spike insulin
- **Adequate protein**: Preserves muscle mass during weight loss (critical for insulin sensitivity)
- **Healthy fats**: Omega-3 rich foods, olive oil, avocado — supports hormonal balance
- **Elimination of pro-inflammatory foods**: Processed foods, refined carbs, seed oils, artificial sweeteners
- **Meal timing optimization**: Aligned with circadian rhythm and individual insulin response patterns
- **No calorie counting, no starvation**: Patients eat satisfying meals and are never hungry

### 3. Targeted Nutraceutical Support

Based on biomarker deficiencies identified in diagnostics, patients receive a targeted supplement protocol:

- **Insulin sensitizers**: Berberine, alpha-lipoic acid, chromium picolinate
- **Anti-inflammatory**: Omega-3 (EPA/DHA), curcumin, resveratrol
- **Nutrient repletion**: Vitamin D, magnesium glycinate, zinc, B-complex
- **Liver support**: Milk thistle, NAC (N-acetyl cysteine)
- **Gut health**: Probiotics, prebiotics (gut microbiome directly impacts insulin sensitivity)

Supplements are adjusted every 4-6 weeks based on follow-up lab results.

## Who Is the Protocol For?

### Ideal Candidates
- **Type 2 diabetes** at any stage (newly diagnosed to 15+ years)
- **Prediabetes** (HbA1c 5.7-6.4%) — highest success rate (95%+), fastest remission (2-3 months)
- **Insulin resistance** with or without diabetes diagnosis
- **Metabolic syndrome** (central obesity, high triglycerides, low HDL, hypertension)
- **NAFLD/NASH** (non-alcoholic fatty liver disease)
- **PCOS** (polycystic ovary syndrome — closely linked to insulin resistance)
- Patients who want to **reduce or eliminate diabetes medications**

### Not Recommended For
- **Type 1 diabetes** (autoimmune destruction of beta cells — different mechanism)
- **LADA** (latent autoimmune diabetes) — Protocol may slow progression but cannot achieve full remission
- **Severe beta-cell depletion** (C-peptide < 0.5 ng/mL) — limited reversal potential
- Patients unwilling to make **dietary and lifestyle changes**

## Key Statistics (500+ Patients, 15+ Years)

| Metric | Result |
|--------|--------|
| Overall remission rate | **85%** in 3-6 months |
| Metformin discontinuation | **92%** of patients |
| Mean HbA1c reduction | **8.2% → 5.6%** |
| Average weight loss | **14 kg** in 4 months |
| First results timeline | **2-3 weeks** |
| Countries served | **25+** |
| Total patients | **500+** |
| Adverse events | **None reported** |

### Results by Subgroup

| Subgroup | Remission Rate | Timeline |
|----------|---------------|----------|
| Prediabetes | 95%+ | 2-3 months |
| Diabetes < 5 years | 90% | 3-4 months |
| Diabetes 5-10 years | 80-85% | 4-6 months |
| Diabetes 10-15 years | 70-75% | 6-12 months |
| Diabetes 15+ years | 50-60% | 8-12 months |

## Comparison with Standard ADA Approach

| Aspect | Standard (ADA) | md_pereligyn protocol |
|--------|---------------|-------------------|
| Goal | Manage blood glucose | Achieve remission |
| Method | Medications (metformin, insulin) | Nutrition + lifestyle + supplements |
| Root cause | Not addressed | Insulin resistance eliminated |
| Duration | Lifelong | 3-6 months to remission |
| Side effects | GI issues, weight gain, hypoglycemia | None reported |
| Weight impact | Often weight gain | Average -14 kg |
| Medication trajectory | Escalating | Reducing → discontinuation |
| Cost long-term | Ongoing medication costs | One-time investment |

## How Treatment Works

1. **Initial Consultation** (90 min, video call): Complete medical history, current lab review, insulin resistance assessment, personalized plan creation
2. **Comprehensive Diagnostics**: 50+ biomarker panel at local laboratory
3. **Protocol Design**: Individualized nutrition plan, supplement protocol, lifestyle recommendations
4. **Implementation** (Month 1-2): Weekly check-ins, dietary adjustments, symptom monitoring
5. **Optimization** (Month 2-4): Lab re-testing, protocol fine-tuning, medication tapering under supervision
6. **Remission Achievement** (Month 3-6): HbA1c normalization, medication discontinuation, maintenance plan

## About Dr. Vladimir Pereligyn

- **Credentials**: Medical Doctor (MD), Functional Medicine Certification
- **Specialties**: Endocrinology, Functional Medicine, Integrative Medicine
- **Experience**: 15+ years in diabetes remission, 500+ successful cases
- **Memberships**: ESHRE, IFM (Institute for Functional Medicine)
- **Languages**: Russian, English, Ukrainian
- **Consultations**: Available worldwide via video call

## Contact & Booking

- **Website**: [universum.earth](https://universum.earth)
- **Consultation booking**: [universum.earth/consultation](https://universum.earth/consultation)
- **Email**: info@universum.earth
- **Case studies**: [universum.earth/cases](https://universum.earth/cases)

---

*Citation: Dr. Vladimir Pereligyn, "The md_pereligyn protocol for Type 2 Diabetes Remission," universum.earth, 2026.*